Tenapanor Completed Phase 4 Trials for Chronic Kidney Disease Requiring Chronic Dialysis / Hyperphosphataemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04549597Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia